These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18366688)

  • 1. Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: a historic prospective study.
    Baltzell KA; Moghadassi M; Rice T; Sison JD; Wrensch M
    BMC Cancer; 2008 Mar; 8():75. PubMed ID: 18366688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
    Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
    Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid.
    Wrensch MR; Petrakis NL; Miike R; King EB; Chew K; Neuhaus J; Lee MM; Rhys M
    J Natl Cancer Inst; 2001 Dec; 93(23):1791-8. PubMed ID: 11734595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls.
    Fought AJ; McGathey C; Scholtens DM; Heinz RE; Lowe R; Feeney YB; Lee O; Kmiecik TE; Wolfman JA; Clevenger CV; Gann PH; Gapstur S; Chatterton RT; Khan SA
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2277-84. PubMed ID: 24049126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative epithelial disease identified in nipple aspirate fluid and risk of developing breast cancer: a systematic review.
    Hornberger J; Chen SC; Li Q; Kakad P; Quay SC
    Curr Med Res Opin; 2015 Feb; 31(2):253-62. PubMed ID: 25405383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional breast biopsy.
    Sauter ER; Ehya H; Mammen A; Klein G
    Br J Cancer; 2001 Dec; 85(12):1952-7. PubMed ID: 11747339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional predictors for cellular nipple aspirate fluid: Nutrition and Breast Health Study.
    Kato I; Ren J; Visscher DW; Djuric Z
    Breast Cancer Res Treat; 2006 May; 97(1):33-9. PubMed ID: 16317581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of abnormal nipple aspirate cytology and mammographic pattern and density.
    Lee MM; Petrakis NL; Wrensch MR; King EB; Miike R; Sickles E
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):33-6. PubMed ID: 8118383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid.
    Wrensch MR; Petrakis NL; King EB; Miike R; Mason L; Chew KL; Lee MM; Ernster VL; Hilton JF; Schweitzer R
    Am J Epidemiol; 1992 Jan; 135(2):130-41. PubMed ID: 1536131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nipple aspirate fluid color is associated with breast cancer.
    Sauter ER; Winn JN; Dale PS; Wagner-Mann C
    Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sampling for increasing the diagnostic sensitivity of nipple aspirate fluid for atypical cytology.
    King EB; Chew KL; Hom JD; Miike R; Wrensch MR; Petrakis NL
    Acta Cytol; 2004; 48(6):813-7. PubMed ID: 15581167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer.
    Mannello F; Tonti GA; Medda V; Pederzoli A; Sauter ER
    Cancer Sci; 2008 Nov; 99(11):2160-9. PubMed ID: 18811693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
    Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
    Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens.
    Sharma P; Klemp JR; Simonsen M; Welsko CM; Zalles CM; Kimler BF; Fabian CJ
    Breast Cancer Res Treat; 2004 Sep; 87(1):59-64. PubMed ID: 15377851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer.
    Sauter ER; Chervoneva I; Diamandis A; Khosravi JM; Litwin S; Diamandis EP
    Cancer Detect Prev; 2002; 26(2):149-57. PubMed ID: 12102150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
    Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk.
    Sauter ER; Ross E; Daly M; Klein-Szanto A; Engstrom PF; Sorling A; Malick J; Ehya H
    Br J Cancer; 1997; 76(4):494-501. PubMed ID: 9275027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
    Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
    Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer.
    Paweletz CP; Trock B; Pennanen M; Tsangaris T; Magnant C; Liotta LA; Petricoin EF
    Dis Markers; 2001; 17(4):301-7. PubMed ID: 11790897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.